{
    "info": {
        "nct_id": "NCT03304639",
        "official_title": "A Randomized Phase II Study of Anti-PD1 Antibody [MK-3475 (Pembrolizumab)] Alone Versus Anti-PD1 Antibody Plus Stereotactic Body Radiation Therapy in Advanced Merkel Cell Carcinoma",
        "inclusion_criteria": "* Patients must have pathologically (histologically or cytologically) proven diagnosis of MCC by local pathology review\n* Have measurable disease based on RECIST 1.1 including at least two cancerous deposits; at least one deposit must be RECIST measurable while at least one deposit must meet criteria for SBRT; non-radiated tumor will be identified prior to randomization on the protocol\n* Patients must have advanced or metastatic MCC defined as evidence of distant metastasis(es) on imaging\n\n  * Patients with locoregionally confined disease are not eligible\n* No prior immunotherapy for advanced/metastatic MCC\n* Patients with known or suspected central nervous system (CNS) metastases, untreated CNS metastases, or with the CNS as the only site of disease are excluded; however, subjects with controlled brain metastases will be allowed to enroll; controlled brain metastases are defined as no radiographic progression for at least 4 weeks following radiation and/or surgical treatment (or 4 weeks of observation if no intervention is clinically indicated), and off of steroids for at least 2 weeks, and no new or progressive neurological signs and symptoms\n* Patients having received palliative radiotherapy for extracranial metastasis(es) are eligible as long as there are 2 cancerous deposits that have not received prior radiation therapy (RT) and they meet the following criteria\n\n  * No prior radiation therapy (> 5 Gy) to the metastasis intended to be treated with SBRT\n* No history of the following:\n\n  * Autoimmunity requiring systemic immunosuppression within 2 years\n  * Patients known to be human immunodeficiency virus (HIV) positive are eligible if they meet the following:\n\n    * CD4 counts >= 350 mm^3\n    * Serum HIV viral load of < 25,000 IU/ml\n* No other active malignancy that the investigator determines would interfere with the treatment and safety analysis\n* Not pregnant and not nursing, because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn are unknown; therefore, for women of childbearing potential only, a negative (if your test schedule specifically indicates a urine or serum pregnancy test, add that information at this point) pregnancy test done =< 28 days prior to registration is required\n* Eastern Cooperative Oncology Group (ECOG) performance status 0-2\n* Absolute neutrophil count (ANC) >= 1,500/mm^3\n* Platelet count >= 100,000/mm^3\n* Hemoglobin >= 9.0 g/dl\n* Total bilirubin =< 2.0 mg/dl\n* Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< 3.0 x upper limit of normal (ULN)\n* Systolic blood pressure (BP) =< 150 mg HG\n* Diastolic BP =< 90 mg HG\n* Albumin > 3 mg/dl\n* Blood urea nitrogen (BUN) =< 30 mg/dl\n* Creatinine =< 1.7 mg/dl\n* The following imaging workup to document metastases within 45 days prior to study registration are required: CT scans of the chest, abdomen and pelvis with radionuclide bone scan OR whole body (at least skull base to midthigh) positron emission tomography (PET)/CT\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients with locoregionally confined disease are not eligible",
            "criterions": [
                {
                    "exact_snippets": "Patients with locoregionally confined disease are not eligible",
                    "criterion": "locoregionally confined disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Systolic blood pressure (BP) =< 150 mg HG",
            "criterions": [
                {
                    "exact_snippets": "Systolic blood pressure (BP) =< 150 mg HG",
                    "criterion": "systolic blood pressure",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 150,
                                "unit": "mg HG"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Serum HIV viral load of < 25,000 IU/ml",
            "criterions": [
                {
                    "exact_snippets": "Serum HIV viral load of < 25,000 IU/ml",
                    "criterion": "serum HIV viral load",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 25000,
                                "unit": "IU/ml"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* No prior immunotherapy for advanced/metastatic MCC",
            "criterions": [
                {
                    "exact_snippets": "No prior immunotherapy for advanced/metastatic MCC",
                    "criterion": "prior immunotherapy for advanced/metastatic MCC",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients must have pathologically (histologically or cytologically) proven diagnosis of MCC by local pathology review",
            "criterions": [
                {
                    "exact_snippets": "pathologically (histologically or cytologically) proven diagnosis of MCC by local pathology review",
                    "criterion": "Merkel cell carcinoma (MCC) diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": [
                                "histologically",
                                "cytologically"
                            ]
                        },
                        {
                            "requirement_type": "confirmation authority",
                            "expected_value": "local pathology review"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients having received palliative radiotherapy for extracranial metastasis(es) are eligible as long as there are 2 cancerous deposits that have not received prior radiation therapy (RT) and they meet the following criteria",
            "criterions": [
                {
                    "exact_snippets": "Patients having received palliative radiotherapy for extracranial metastasis(es) are eligible",
                    "criterion": "palliative radiotherapy for extracranial metastasis(es)",
                    "requirements": [
                        {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "as long as there are 2 cancerous deposits that have not received prior radiation therapy (RT)",
                    "criterion": "cancerous deposits",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "deposits"
                            }
                        },
                        {
                            "requirement_type": "prior radiation therapy",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* No other active malignancy that the investigator determines would interfere with the treatment and safety analysis",
            "criterions": [
                {
                    "exact_snippets": "No other active malignancy",
                    "criterion": "other active malignancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "the investigator determines would interfere with the treatment and safety analysis",
                    "criterion": "malignancy interference with treatment and safety analysis (as determined by investigator)",
                    "requirements": [
                        {
                            "requirement_type": "interference with treatment and safety analysis (as determined by investigator)",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* CD4 counts >= 350 mm^3",
            "criterions": [
                {
                    "exact_snippets": "CD4 counts >= 350 mm^3",
                    "criterion": "CD4 count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 350,
                                "unit": "mm^3"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Autoimmunity requiring systemic immunosuppression within 2 years",
            "criterions": [
                {
                    "exact_snippets": "Autoimmunity requiring systemic immunosuppression within 2 years",
                    "criterion": "autoimmunity",
                    "requirements": [
                        {
                            "requirement_type": "treatment requirement",
                            "expected_value": "systemic immunosuppression"
                        },
                        {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Creatinine =< 1.7 mg/dl",
            "criterions": [
                {
                    "exact_snippets": "Creatinine =< 1.7 mg/dl",
                    "criterion": "creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.7,
                                "unit": "mg/dl"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients with known or suspected central nervous system (CNS) metastases, untreated CNS metastases, or with the CNS as the only site of disease are excluded; however, subjects with controlled brain metastases will be allowed to enroll; controlled brain metastases are defined as no radiographic progression for at least 4 weeks following radiation and/or surgical treatment (or 4 weeks of observation if no intervention is clinically indicated), and off of steroids for at least 2 weeks, and no new or progressive neurological signs and symptoms",
            "criterions": [
                {
                    "exact_snippets": "known or suspected central nervous system (CNS) metastases",
                    "criterion": "central nervous system (CNS) metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "untreated CNS metastases",
                    "criterion": "untreated CNS metastases",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "untreated"
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "CNS as the only site of disease",
                    "criterion": "CNS as the only site of disease",
                    "requirements": [
                        {
                            "requirement_type": "site of disease",
                            "expected_value": "not CNS only"
                        }
                    ]
                },
                {
                    "exact_snippets": "controlled brain metastases ... no radiographic progression for at least 4 weeks following radiation and/or surgical treatment (or 4 weeks of observation if no intervention is clinically indicated)",
                    "criterion": "brain metastases radiographic progression",
                    "requirements": [
                        {
                            "requirement_type": "progression-free duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "off of steroids for at least 2 weeks",
                    "criterion": "steroid use",
                    "requirements": [
                        {
                            "requirement_type": "off steroids duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "weeks"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "no new or progressive neurological signs and symptoms",
                    "criterion": "neurological signs and symptoms",
                    "requirements": [
                        {
                            "requirement_type": "new or progressive",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Platelet count >= 100,000/mm^3",
            "criterions": [
                {
                    "exact_snippets": "Platelet count >= 100,000/mm^3",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100000,
                                "unit": "mm^3"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hemoglobin >= 9.0 g/dl",
            "criterions": [
                {
                    "exact_snippets": "Hemoglobin >= 9.0 g/dl",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 9.0,
                                "unit": "g/dl"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Albumin > 3 mg/dl",
            "criterions": [
                {
                    "exact_snippets": "Albumin > 3 mg/dl",
                    "criterion": "albumin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 3,
                                "unit": "mg/dl"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Total bilirubin =< 2.0 mg/dl",
            "criterions": [
                {
                    "exact_snippets": "Total bilirubin =< 2.0 mg/dl",
                    "criterion": "total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.0,
                                "unit": "mg/dl"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Not pregnant and not nursing, because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn are unknown; therefore, for women of childbearing potential only, a negative (if your test schedule specifically indicates a urine or serum pregnancy test, add that information at this point) pregnancy test done =< 28 days prior to registration is required",
            "criterions": [
                {
                    "exact_snippets": "Not pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "not nursing",
                    "criterion": "nursing status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "for women of childbearing potential only, a negative ... pregnancy test done =< 28 days prior to registration is required",
                    "criterion": "pregnancy test result",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": {
                                "operator": "<=",
                                "value": 28,
                                "unit": "days prior to registration"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Blood urea nitrogen (BUN) =< 30 mg/dl",
            "criterions": [
                {
                    "exact_snippets": "Blood urea nitrogen (BUN) =< 30 mg/dl",
                    "criterion": "blood urea nitrogen (BUN)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "mg/dl"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have measurable disease based on RECIST 1.1 including at least two cancerous deposits; at least one deposit must be RECIST measurable while at least one deposit must meet criteria for SBRT; non-radiated tumor will be identified prior to randomization on the protocol",
            "criterions": [
                {
                    "exact_snippets": "measurable disease based on RECIST 1.1",
                    "criterion": "disease measurability (RECIST 1.1)",
                    "requirements": [
                        {
                            "requirement_type": "measurability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "criteria",
                            "expected_value": "RECIST 1.1"
                        }
                    ]
                },
                {
                    "exact_snippets": "at least two cancerous deposits",
                    "criterion": "number of cancerous deposits",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "deposits"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "at least one deposit must be RECIST measurable",
                    "criterion": "RECIST measurable deposit",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "deposit"
                            }
                        },
                        {
                            "requirement_type": "measurability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "criteria",
                            "expected_value": "RECIST"
                        }
                    ]
                },
                {
                    "exact_snippets": "at least one deposit must meet criteria for SBRT",
                    "criterion": "deposit meeting SBRT criteria",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "deposit"
                            }
                        },
                        {
                            "requirement_type": "criteria",
                            "expected_value": "SBRT"
                        }
                    ]
                },
                {
                    "exact_snippets": "non-radiated tumor will be identified prior to randomization",
                    "criterion": "identification of non-radiated tumor",
                    "requirements": [
                        {
                            "requirement_type": "identification",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to randomization"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients must have advanced or metastatic MCC defined as evidence of distant metastasis(es) on imaging",
            "criterions": [
                {
                    "exact_snippets": "Patients must have advanced or metastatic MCC",
                    "criterion": "Merkel cell carcinoma (MCC) stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "advanced",
                                "metastatic"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "evidence of distant metastasis(es) on imaging",
                    "criterion": "distant metastasis on imaging",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* No prior radiation therapy (> 5 Gy) to the metastasis intended to be treated with SBRT",
            "criterions": [
                {
                    "exact_snippets": "No prior radiation therapy (> 5 Gy) to the metastasis intended to be treated with SBRT",
                    "criterion": "prior radiation therapy to the metastasis intended to be treated with SBRT",
                    "requirements": [
                        {
                            "requirement_type": "dose",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "Gy"
                            }
                        },
                        {
                            "requirement_type": "history",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients known to be human immunodeficiency virus (HIV) positive are eligible if they meet the following:",
            "criterions": [
                {
                    "exact_snippets": "Patients known to be human immunodeficiency virus (HIV) positive",
                    "criterion": "HIV status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* No history of the following:",
            "criterions": [
                {
                    "exact_snippets": "No history of the following:",
                    "criterion": "history of specified conditions",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* The following imaging workup to document metastases within 45 days prior to study registration are required: CT scans of the chest, abdomen and pelvis with radionuclide bone scan OR whole body (at least skull base to midthigh) positron emission tomography (PET)/CT",
            "criterions": [
                {
                    "exact_snippets": "imaging workup to document metastases within 45 days prior to study registration are required",
                    "criterion": "imaging workup for metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 45,
                                "unit": "days prior to study registration"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "CT scans of the chest, abdomen and pelvis",
                    "criterion": "CT scans of chest, abdomen, and pelvis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "radionuclide bone scan OR whole body (at least skull base to midthigh) positron emission tomography (PET)/CT",
                    "criterion": "radionuclide bone scan or whole body PET/CT",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "anatomic coverage",
                            "expected_value": "at least skull base to midthigh"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Eastern Cooperative Oncology Group (ECOG) performance status 0-2",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status 0-2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Diastolic BP =< 90 mg HG",
            "criterions": [
                {
                    "exact_snippets": "Diastolic BP =< 90 mg HG",
                    "criterion": "diastolic blood pressure",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": "<=",
                                "value": 90,
                                "unit": "mm Hg"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Absolute neutrophil count (ANC) >= 1,500/mm^3",
            "criterions": [
                {
                    "exact_snippets": "Absolute neutrophil count (ANC) >= 1,500/mm^3",
                    "criterion": "absolute neutrophil count (ANC)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1500,
                                "unit": "mm^3"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "* Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< 3.0 x upper limit of normal (ULN)",
            "criterions": [
                {
                    "exact_snippets": "Aspartate aminotransferase (AST) =< 3.0 x upper limit of normal (ULN)",
                    "criterion": "aspartate aminotransferase (AST)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3.0,
                                "unit": "x ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "alanine aminotransferase (ALT) =< 3.0 x upper limit of normal (ULN)",
                    "criterion": "alanine aminotransferase (ALT)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3.0,
                                "unit": "x ULN"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}